- Report
- February 2026
- 250 Pages
Global
From €3998EUR$4,490USD£3,433GBP
- Report
- February 2026
- 250 Pages
Global
From €3998EUR$4,490USD£3,433GBP
- Report
- February 2026
- 250 Pages
Global
From €3998EUR$4,490USD£3,433GBP
- Report
- September 2026
- 382 Pages
Global
From €5209EUR$5,850USD£4,473GBP
- Report
- September 2026
- 292 Pages
Global
From €5209EUR$5,850USD£4,473GBP
- Report
- September 2026
- 287 Pages
Global
From €5209EUR$5,850USD£4,473GBP
- Report
- September 2026
- 1417 Pages
Global
From €5209EUR$5,850USD£4,473GBP
- Report
- September 2026
- 158 Pages
Global
From €5209EUR$5,850USD£4,473GBP
- Report
- September 2026
- 182 Pages
Global
From €5209EUR$5,850USD£4,473GBP
- Report
- September 2026
- 586 Pages
Global
From €5209EUR$5,850USD£4,473GBP
- Report
- January 2026
- 80 Pages
Global
From €1781EUR$2,000USD£1,529GBP
- Report
- August 2026
- 190 Pages
Global
From €4229EUR$4,750USD£3,632GBP
- Report
- August 2026
- 131 Pages
Global
From €4229EUR$4,750USD£3,632GBP
- Report
- August 2026
- 185 Pages
Global
From €4229EUR$4,750USD£3,632GBP
- Report
- July 2026
- 120 Pages
Global
From €4229EUR$4,750USD£3,632GBP
- Report
- July 2026
- 115 Pages
Global
From €4229EUR$4,750USD£3,632GBP
- Report
- July 2026
- 110 Pages
Global
From €4229EUR$4,750USD£3,632GBP
- Report
- July 2026
- 180 Pages
Global
From €4229EUR$4,750USD£3,632GBP
- Report
- June 2026
- 150 Pages
Global
From €4229EUR$4,750USD£3,632GBP
- Report
- July 2026
- 160 Pages
Global
From €2956EUR$3,320USD£2,538GBP
€3695EUR$4,150USD£3,173GBP

Severe Acute Respiratory Syndrome (SARS) is a contagious respiratory illness caused by a virus. Diagnostics for SARS involve laboratory tests to detect the virus or its genetic material in a sample taken from the patient. Diagnostic tests for SARS include reverse transcription-polymerase chain reaction (RT-PCR), antigen-capture enzyme-linked immunosorbent assay (ELISA), and nucleic acid hybridization. These tests are used to detect the presence of the virus in a patient's sample and to differentiate between SARS and other respiratory illnesses.
Diagnostics for SARS are important for early detection and treatment of the disease. Early diagnosis and treatment can reduce the severity of the illness and prevent its spread. Diagnostics for SARS are also used to monitor the spread of the virus and to track its evolution.
Companies in the SARS diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more